These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 31081900)

  • 1. Glucocorticoid-Induced Bone Fragility Is Prevented in Female Mice by Blocking Pyk2/Anoikis Signaling.
    Sato AY; Cregor M; McAndrews K; Li T; Condon KW; Plotkin LI; Bellido T
    Endocrinology; 2019 Jul; 160(7):1659-1673. PubMed ID: 31081900
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glucocorticoids induce osteocyte apoptosis by blocking focal adhesion kinase-mediated survival. Evidence for inside-out signaling leading to anoikis.
    Plotkin LI; Manolagas SC; Bellido T
    J Biol Chem; 2007 Aug; 282(33):24120-30. PubMed ID: 17581824
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Defective microtubule-dependent podosome organization in osteoclasts leads to increased bone density in Pyk2(-/-) mice.
    Gil-Henn H; Destaing O; Sims NA; Aoki K; Alles N; Neff L; Sanjay A; Bruzzaniti A; De Camilli P; Baron R; Schlessinger J
    J Cell Biol; 2007 Sep; 178(6):1053-64. PubMed ID: 17846174
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activation of dimeric glucocorticoid receptors in osteoclast progenitors potentiates RANKL induced mature osteoclast bone resorbing activity.
    Conaway HH; Henning P; Lie A; Tuckermann J; Lerner UH
    Bone; 2016 Dec; 93():43-54. PubMed ID: 27596806
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Notch2 signaling promotes osteoclast resorption via activation of PYK2.
    Jin WJ; Kim B; Kim JW; Kim HH; Ha H; Lee ZH
    Cell Signal; 2016 May; 28(5):357-365. PubMed ID: 26829213
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A bisphosphonate that does not affect osteoclasts prevents osteoblast and osteocyte apoptosis and the loss of bone strength induced by glucocorticoids in mice.
    Plotkin LI; Bivi N; Bellido T
    Bone; 2011 Jul; 49(1):122-7. PubMed ID: 20736091
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Src kinase activity is essential for osteoclast function.
    Miyazaki T; Sanjay A; Neff L; Tanaka S; Horne WC; Baron R
    J Biol Chem; 2004 Apr; 279(17):17660-6. PubMed ID: 14739300
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glucocorticoids act directly on osteoclasts to increase their life span and reduce bone density.
    Jia D; O'Brien CA; Stewart SA; Manolagas SC; Weinstein RS
    Endocrinology; 2006 Dec; 147(12):5592-9. PubMed ID: 16935844
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pyk2 deficiency potentiates osteoblast differentiation and mineralizing activity in response to estrogen or raloxifene.
    Posritong S; Hong JM; Eleniste PP; McIntyre PW; Wu JL; Himes ER; Patel V; Kacena MA; Bruzzaniti A
    Mol Cell Endocrinol; 2018 Oct; 474():35-47. PubMed ID: 29428397
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evidence that activation of ASIC1a by acidosis increases osteoclast migration and adhesion by modulating integrin/Pyk2/Src signaling pathway.
    Li X; Ye JX; Xu MH; Zhao MD; Yuan FL
    Osteoporos Int; 2017 Jul; 28(7):2221-2231. PubMed ID: 28462470
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulation of osteoclast structure and function by FAK family kinases.
    Ray BJ; Thomas K; Huang CS; Gutknecht MF; Botchwey EA; Bouton AH
    J Leukoc Biol; 2012 Nov; 92(5):1021-8. PubMed ID: 22941736
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pyk2 and Megakaryocytes Regulate Osteoblast Differentiation and Migration Via Distinct and Overlapping Mechanisms.
    Eleniste PP; Patel V; Posritong S; Zero O; Largura H; Cheng YH; Himes ER; Hamilton M; Ekwealor JTB; Kacena MA; Bruzzaniti A
    J Cell Biochem; 2016 Jun; 117(6):1396-406. PubMed ID: 26552846
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Myristoleic acid inhibits osteoclast formation and bone resorption by suppressing the RANKL activation of Src and Pyk2.
    Kwon JO; Jin WJ; Kim B; Kim HH; Lee ZH
    Eur J Pharmacol; 2015 Dec; 768():189-98. PubMed ID: 26528796
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Osteoprotegerin induces podosome disassembly in osteoclasts through calcium, ERK, and p38 MAPK signaling pathways.
    Zhao H; Liu X; Zou H; Dai N; Yao L; Gao Q; Liu W; Gu J; Yuan Y; Bian J; Liu Z
    Cytokine; 2015 Feb; 71(2):199-206. PubMed ID: 25461399
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Promotion of osteoclast survival and antagonism of bisphosphonate-induced osteoclast apoptosis by glucocorticoids.
    Weinstein RS; Chen JR; Powers CC; Stewart SA; Landes RD; Bellido T; Jilka RL; Parfitt AM; Manolagas SC
    J Clin Invest; 2002 Apr; 109(8):1041-8. PubMed ID: 11956241
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glucocorticoids suppress bone formation via the osteoclast.
    Kim HJ; Zhao H; Kitaura H; Bhattacharyya S; Brewer JA; Muglia LJ; Ross FP; Teitelbaum SL
    J Clin Invest; 2006 Aug; 116(8):2152-60. PubMed ID: 16878176
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Noncanonical G-protein-dependent modulation of osteoclast differentiation and bone resorption mediated by Pasteurella multocida toxin.
    Strack J; Heni H; Gilsbach R; Hein L; Aktories K; Orth JH
    mBio; 2014 Nov; 5(6):e02190. PubMed ID: 25389180
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preservation of type H vessels and osteoblasts by enhanced preosteoclast platelet-derived growth factor type BB attenuates glucocorticoid-induced osteoporosis in growing mice.
    Yang P; Lv S; Wang Y; Peng Y; Ye Z; Xia Z; Ding G; Cao X; Crane JL
    Bone; 2018 Sep; 114():1-13. PubMed ID: 29800693
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MicroRNA-29a protects against glucocorticoid-induced bone loss and fragility in rats by orchestrating bone acquisition and resorption.
    Wang FS; Chuang PC; Lin CL; Chen MW; Ke HJ; Chang YH; Chen YS; Wu SL; Ko JY
    Arthritis Rheum; 2013 Jun; 65(6):1530-40. PubMed ID: 23529662
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PYK2 in osteoclasts is an adhesion kinase, localized in the sealing zone, activated by ligation of alpha(v)beta3 integrin, and phosphorylated by src kinase.
    Duong LT; Lakkakorpi PT; Nakamura I; Machwate M; Nagy RM; Rodan GA
    J Clin Invest; 1998 Sep; 102(5):881-92. PubMed ID: 9727056
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.